NCT06434168

Brief Summary

Mild cognitive impairment is highly prevalent in patients with heart failure and results in poor well-being and quality of life. While yoga has proven effective in promoting cognitive health in older adults through its gentle movements, controlled breathing, and meditation, its effects on patients with heart failure remain unknown. Therefore, this feasibility and pilot study plans to deliver a 12-week yoga intervention and test its effects on cognitive function in patients with heart failure and mild cognitive impairment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
24

participants targeted

Target at below P25 for not_applicable heart-failure

Timeline
Completed

Started Jul 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

May 30, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

July 1, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 30, 2024

Status Verified

May 1, 2024

Enrollment Period

12 months

First QC Date

May 21, 2024

Last Update Submit

May 23, 2024

Conditions

Keywords

Yoga interventioncognitive function

Outcome Measures

Primary Outcomes (4)

  • Brain structure

    Using structural magnetic resonance imaging to examine brain structure between intervention and control groups. Less brain alteration is optimal.

    Change from 0-12 weeks, from baseline pre-intervention to 12 weeks post-intervention

  • Brain functional connectivity

    Functional magnetic resonance imaging is used to examine functional connectivity between intervention and control groups. A balance of activity across different brain regions is optimal.

    Change from 0-12 weeks, from baseline pre-intervention to 12 weeks post-intervention

  • Cognitive function

    Using cognitive tests to examine cognitive function and performance between intervention and control groups. A higher score on cognitive tests indicates better cognitive function.

    Change from 0-12 weeks, from baseline pre-intervention to 12 weeks post-intervention

  • Serum brain-derived neurotrophic factor

    A blood sample will be obtained using phlebotomy to measure the levels of serum brain-derived neurotrophic factor and reported in pg/mL. Higher concentrations are optimal.

    Change from 0-12 weeks, from baseline pre-intervention to 12 weeks post-intervention

Study Arms (2)

Yoga intervention

EXPERIMENTAL
Behavioral: Yoga intervention

Control condition

PLACEBO COMPARATOR
Behavioral: Control condition

Interventions

Patients in the yoga group will receive a 60-minute session, twice per week over 12 weeks for a total of 24 sessions. Each yoga session consists of a warm-up, yoga postures standing or seated depending on the capability of the patient, and relaxation.

Yoga intervention

Patients in the control group will receive care-as-usual from their healthcare providers and will be asked to avoid engaging in yoga during their 3 months in the study.

Control condition

Eligibility Criteria

Age55 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 55 years and older
  • Confirmed heart failure diagnosis with mild cognitive impairment
  • New York Heart Association functional class II-IV

You may not qualify if:

  • Co-existing neurological disorders, traumatic brain injury, psychiatric disorders, or terminal illnesses
  • Have implanted defibrillator, left ventricular assist device placement or cardiac transplant
  • Have any other implanted metals that interfere with the MRI magnetic field for patient safety
  • Substance abuse
  • Pregnant
  • Unable to perform yoga due to physical limitations or severity of illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Auburn University

Auburn, Alabama, 36849, United States

Location

MeSH Terms

Conditions

Heart FailureCognitive Dysfunction

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Central Study Contacts

Chin-Yen Lin, RN, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

May 21, 2024

First Posted

May 30, 2024

Study Start

July 1, 2024

Primary Completion

June 30, 2025

Study Completion

December 31, 2025

Last Updated

May 30, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations